Trial intelligence / Profile preview

PRF in Osseous Regeneration After Cystic Enucleation

NCT07424716Recruiting

Sponsor
Sana'a University
Start
May 2025
Primary completion
Apr 2026
Modality
Device-based Delivery
Countries
1
01

Overview

Randomised trial of platelet rich fibrin in Bone defect (2 arms), sponsored by Sana'a University. Primary endpoint: Radiographic bone regeneration in cystic defects following enucleation at 6 months. Started May 2025; status: recruiting.

02

Drugs

platelet rich fibrin
03

Conditions

Bone defect

Beyond the preview

Go deeper on NCT07424716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07424716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call